INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
FE
Feder EricDirector
HIPOHippo Holdings Inc.
Grant or award
A$120K
4,738 sh
Jun 2, 2026Jun 4, 2026
Page 726 of 1737
← PrevNext →
traded Jun 2, 2026
+2d
SEC Form 4

Evidence

20
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
8,074 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
LJ
Liang JanetPresident, Oscar Insurance
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
3,535 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
MA
McAnaney AdamChief Legal Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
2,794 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Option exercise
M$314K
25.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
MA
McAnaney AdamChief Legal Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$154K
7,065 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
EM
Eckert Kurt M.Director
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$224K
5,250 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Tax withholding
F$437K
17.3K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$532K
24.5K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
VD
Verdeschi Michael DCFO
SCHWSCHWAB CHARLES CORP
Tax withholding
F$570K
6,519 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

19
LJ
Liang JanetPresident, Oscar Insurance
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
8,940 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

19
NC
Natali ChrisSVP, Chief Accounting Officer
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
552 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

19
BB
Borgeson BlakeDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$110K
30.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

18
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
3,379 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

18
KF
Keller FrankPres., Checkout Sol. & PayPal
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
4,612 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

18
SD
Semler DakotaDirector, Chief Executive Officer
XOSXos, Inc.
Gift
G—
30.0K sh
May 28, 2026Jun 4, 2026
traded May 28, 2026
+7dSEC Form 4

Evidence

17
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$913K
6,727 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
FD
Fouche Lori DickersonDirector
HIPOHippo Holdings Inc.
Grant or award
A—
4,808 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
BB
Baer Daniel BrooksDirector
GRNDGrindr Inc.
Grant or award
A—
13.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
SA
Schot AbrahamDirector
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise
M—
2,919 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

17
DD
Dorsey DonnaDirector
ROOTRoot, Inc.
Grant or award
A—
2,864 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

17
GE
Grabscheid EduardCHIEF FINANCIAL OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$821K
9,484 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
SM
Schaaf MarkDirector
HIPOHippo Holdings Inc.
Grant or award
A—
4,808 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
GE
Grabscheid EduardCHIEF FINANCIAL OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$261K
3,070 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

17
MM
McMurry-Heath MichelleDirector
BVSBioventus Inc.
Option exercise
M—
32.3K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
SG
Snyder Jay GDirector
RMNIRimini Street, Inc.
Option exercise
M—
55.7K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
MC
Marshall CynthiaDirector
CHYMChime Financial, Inc.
Grant or award
A—
10.8K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

17
SJ
Szudarek JulieDirector
ROOTRoot, Inc.
Grant or award
A—
2,864 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

17
ZH
Zak HeidiDirector
CRCTCricut, Inc.
Grant or award
A—
30.4K sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

16
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$378K
40.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

16
BV
Baltrus VictoriaChief Accounting Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9,698
432 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

16
BV
Baltrus VictoriaChief Accounting Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
1,091 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
9,668 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

15
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Tax withholding
F$576K
23.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

15
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Tax withholding
F$576K
23.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

15
KC
Keswani Sanjay ChandruChief Medical Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$268K
1,733 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

14
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$98K
1,961 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

14
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$43K
3,944 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

14
GE
Grabscheid EduardCHIEF FINANCIAL OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$58K
682 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

14
HH
Harris Isaac HosojiroDirector
LITELumentum Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$1.42M
1,416 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence